CAH Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 23:00):

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally...

Stats
Šios dienos apimtis	3.02M
Vidutinė apimtis	2.24M
Rinkos kapitalizacija	25.05B
EPS	$0 ( 2024-02-01 )
Last Dividend	$0.501 ( 2024-03-28 )
Next Dividend	$0 ( N/A )
P/E	40.87
ATR14	$0.0920 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Greene Michelle D.	Sell	664	Common Shares
2024-03-15	Azelby Robert	Buy	1 288	Common Shares
2024-03-01	Azelby Robert	Buy	0
2024-02-15	Alt Aaron E	Sell	1 919	Common Shares
2024-02-15	Greene Michelle D.	Sell	664	Common Shares

INSIDER POWER
3.23
Last 97 transactions
Buy: 387 658 \| Sell: 341 933

Tūris Koreliacija

Ilgas: -0.23 (neutral)

Trumpas: 0.87 (strong)

Signal:(33.987) Same movement expected

Cardinal Health Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
PFGC	0.846
IXJ	0.818

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Cardinal Health Inc Koreliacija - Valiuta/Žaliavos

0.47
( neutral )

0.26
( neutral )

0.00
( neutral )

0.28
( neutral )

-0.84
( strong negative )

0.24
( neutral )

Cardinal Health Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$205.01B
Bruto pelnas:	$6.89B (3.36 %)
EPS:	$1.000

FY	2023
Pajamos:	$205.01B
Bruto pelnas:	$6.89B (3.36 %)
EPS:	$1.000

FY	2023
Pajamos:	$13.00M
Bruto pelnas:	$6.89B (52 992.31 %)
EPS:	$0.940

FY	2022
Pajamos:	$181.36B
Bruto pelnas:	$6.55B (3.61 %)
EPS:	$-3.34

Financial Reports:

No articles found.

Cardinal Health Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.496 (N/A)	$0.496 (N/A)	$0.496 (N/A)	$0.501 (N/A)	$0 (N/A)	$1.001 (N/A)	$0.501 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Cardinal Health Inc Dividend Information - Dividend Knight

Dividend Sustainability Score: 4.31 - low (43.22%) | Divividend Growth Potential Score: 2.09 - Decrease likely (58.20%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00201	1986-12-24
Last Dividend	$0.501	2024-03-28
Next Dividend	$0	N/A
Payout Date	2024-04-15
Next Payout Date	N/A
# dividends	151	--
Total Paid Out	$35.17	--
Avg. Dividend % Per Year	2.37%	--
Score	4.41	--
Div. Sustainability Score	4.31
Div.Growth Potential Score	2.09
Div. Directional Score	3.20	--

Next Divdend (Est)
(2024-07-03)

$0.503 Estimate 39.73 %

Dividend Stability

0.79 Good

Dividend Score

4.41

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1986	$0.00201	0.10%
1987	$0.00844	0.47%
1988	$0.00928	0.79%
1989	$0.0103	0.51%
1990	$0.0129	0.35%
1991	$0.0161	0.32%
1992	$0.0202	0.29%
1993	$0.0249	0.36%
1994	$0.0339	0.31%
1995	$0.0356	0.27%
1996	$0.0378	0.23%
1997	$0.0444	0.17%
1998	$0.0602	0.18%
1999	$0.0674	0.14%
2000	$0.0767	0.23%
2001	$0.0950	0.15%
2002	$0.100	0.16%
2003	$0.115	0.19%
2004	$0.120	0.20%
2005	$0.210	0.37%
2006	$0.330	0.47%
2007	$0.450	0.70%
2008	$0.540	0.95%
2009	$10.42	29.60%
2010	$0.760	2.34%
2011	$0.840	2.16%
2012	$0.966	2.33%
2013	$1.183	2.84%
2014	$1.332	2.01%
2015	$1.504	1.87%
2016	$1.734	1.97%
2017	$1.835	2.46%
2018	$1.890	2.99%
2019	$1.919	4.26%
2020	$1.939	3.87%
2021	$1.959	3.70%
2022	$1.979	3.81%
2023	$1.998	2.60%
2024	$0.501	0.49%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
ZTR	Dividend Royal	2024-02-09	Monthly	37	8.35%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.00296	1.500	9.94	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0137	1.200	9.54	10.00	[0 - 0.3]
returnOnEquityTTM	-0.213	1.500	-3.48	-5.21	[0.1 - 1]
payoutRatioTTM	0.797	-1.000	2.03	-2.03	[0 - 1]
currentRatioTTM	0.984	0.800	-0.0820	-0.0656	[1 - 3]
quickRatioTTM	0.428	0.800	-2.19	-1.752	[0.8 - 2.5]
cashRatioTTM	0.120	1.500	-0.445	-0.667	[0.2 - 2]
debtRatioTTM	0.101	-1.500	8.31	-10.00	[0 - 0.6]
interestCoverageTTM	18.11	1.000	4.40	4.40	[3 - 30]
operatingCashFlowPerShareTTM	16.13	2.00	4.62	9.24	[0 - 30]
freeCashFlowPerShareTTM	13.96	2.00	3.02	6.04	[0 - 20]
debtEquityRatioTTM	-1.369	-1.500	-5.48	8.22	[0 - 2.5]
grossProfitMarginTTM	0.0334	1.000	-2.78	-2.78	[0.2 - 0.8]
operatingProfitMarginTTM	0.00545	1.000	-1.891	-1.891	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.837	1.000	6.46	6.46	[0.2 - 2]
assetTurnoverTTM	4.64	0.800	10.00	8.00	[0.5 - 2]
Total Score				4.31

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	39.17	1.000	6.14	0	[1 - 100]
returnOnEquityTTM	-0.213	2.50	-2.23	-5.21	[0.1 - 1.5]
freeCashFlowPerShareTTM	13.96	2.00	5.35	6.04	[0 - 30]
dividendYielPercentageTTM	1.960	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	16.13	2.00	4.62	9.24	[0 - 30]
payoutRatioTTM	0.797	1.500	2.03	-2.03	[0 - 1]
pegRatioTTM	-0.491	1.500	-6.61	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0183	1.000	-2.04	0	[0.1 - 0.5]
Total Score				2.09

Cardinal Health Inc

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.